1. A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: what do we know, and what are we yet to learn?;Martin;Expert Rev Vaccines,2013
2. Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study;Parikh;Lancet,2016
3. Febrile young infant research collaborative. Variation in care of the febrile young infant;Aronson;Pediatrics,2014
4. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials;Vesikari;Lancet,2013